We take part in leading global pharmaceutical ingredient events to present our statin, SGLT‑2 inhibitor, anti‑tumor and respiratory intermediate portfolio, including atorvastatin calcium intermediates, rosuvastatin calcium intermediates and montelukast intermediate. These activities create face‑to‑face channels for technical exchange, process discussion and joint development planning with global pharmaceutical R&D teams.
Full product portfolio on display with technical experts available for consultation.
Dedicated area highlighting latest R&D achievements and green chemistry advancements.
Meeting space for connecting with global partners, customers, and industry peers.
Exhibitions serve as key windows for Jiangsu Alpha Pharmaceutical to share its latest process progress on statins, dapagliflozin, dabigatran and ibrutinib intermediates. We engage with formulation developers and process researchers to understand evolving purity and delivery requirements. Such on‑site exchanges accelerate technical alignment and promote deeper cooperation on custom intermediate development.
Showcase capabilities to a global audience of industry professionals.
Establish new relationships across the chemical value chain.
Gather intelligence on industry direction and competitor landscape.
Meet existing customers face-to-face and strengthen trust.